Rebecca Boren Perlo, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rebecca Boren Perlo’s office at (650) 575-8506 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$3,260
Pharmacies billed $3,260 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 54) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
49 generic and fewer than 11 brand-name prescriptions · $3,260 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Latanoprost | 12 | $162 | $13 |
Year by year
| 2024 | 54 | 21 | 0% (0) | None | $3,260 |
| 2023 | 293 | 43 | 0% (0) | 14% | $26,248 |
| 2022 | 274 | 58 | 0% (0) | 18% | $18,904 |
| 2021 | 91 | 17 | None | None | $4,144 |
| 2020 | 22 | 11 | None | None | $2,556 |
| 2018 | 33 | 17 | None | 0% | $1,581 |
| 2017 | 55 | 35 | 46% (25) | None | $2,544 |
| 2016 | 73 | 40 | 41% (30) | None | $935 |
| 2015 | 39 | 29 | 59% (23) | 0% | $440 |
| 2014 | 35 | 25 | 57% (20) | None | $552 |
| 2013 | 45 | 34 | 73% (33) | None | $526 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Levothyroxine | 14 | $316 | $23 |
| Atorvastatin | 18 | $277 | $15 |
| Losartan | 12 | $182 | $15 |
2022: 2 drugs
| Levothyroxine | 20 | $435 | $22 |
| Amlodipine Besylate | 18 | $155 | $9 |
2021: 2 drugs
| Azithromycin | 11 | $241 | $22 |
| Amlodipine Besylate | 12 | $48 | $4 |
2017: 1 drug
| Oxycodone | 20 | $89 | $4 |
2016: 1 drug
| Oxycodone | 23 | $184 | $8 |
2015: 1 drug
| Oxycodone | 16 | $125 | $8 |
2014: 1 drug
| Oxycodone | 13 | $97 | $7 |
2013: 1 drug
| Oxycodone | 17 | $92 | $5 |
Money from drug and device companies
$377 in 2025
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | None | $132 | 1 payment
|
| Lilly USA | Zepbound | $123 | 1 payment
|
| ViiV Healthcare | Apretude | $122 | 1 payment
|
See all 3 published payments
| Lilly USA | Meals · 2025-07-17 | Zepbound | $123 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | None | $132 |
| ViiV Healthcare | Meals · 2025-03-13 | Apretude | $122 |
Professional record
- NPI
- 1811914906
- Licence
- CA 57884
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-16
- NPI last updated
- 2020-12-09
- NPI record certified
- 2020-12-09
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.